Drug Development Phase 2 Course
Drug Development Phase 2 Course is organized by Drug Information Association (DIA).
Release Date: June 2, 2021
Expiration Date: June 1, 2024
Course Description:
The Drug Development Phase 2 module is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners will learn about the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.
Featured topics:
• Objectives and Key Players
• Regulatory Activities
• Clinical R&D and Biostatistics Activities
• Case Study Part 1
• End of Phase 2
• Case Study Part 2
• Review
Learning objectives:
Upon completion of this module, learners should be able to:
• List the key objectives and activities of phase 2
• Recognize the regulatory activities and decisions that occur during phase 2
• Identify risk-return decisions involved in phase 2